deuterated cilostazol analogs (CoNCERT)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedeuterated cilostazol analogs (CoNCERT)
Drug Alias NameC-21096C-21095
ClassificationSmall molecules
Mechanisms of ActionPhosphodiesterase 3 inhibitorsPlatelet aggregation inhibitors
TargetsPhosphodiesterase 3
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesConcert Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConcert Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A